BAUMGARTNER ROBERT V — SEC insider filings
SEC reporting owner CIK 1258704. 13 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2020-11-02 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 300 shares, $105,765 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 9 legs across 4 filings — 42,040 shares, $5,570,341 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 5,000 shares @ $303.33 ($1,516,675) in BIO-TECHNE Corp, filed 2020-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIO-TECHNE Corp (TECH) | Director | 13 | 1 leg · 300 sh · $105,765 | 9 legs · 42,040 sh · $5,570,341 | 24 |
Insider filings — BAUMGARTNER ROBERT V
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 2,750 @ $0 | EDGAR |
| 2026-09-24 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 15,940 @ $0 · Tax withholding (F): 5,559 @ $72.55 · Option exercise (M): 15,940 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 1,640 @ $0 · Grant/award (A): 3,777 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 17,040 @ $21.84 · Sale (S): 17,040 @ $56.21 · Option exercise (M): 17,040 (derivative) @ $0 | EDGAR |
| 2024-10-28 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 1,462 @ $0 · Grant/award (A): 3,511 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 16,000 @ $22.95 · Sale (S): 16,000 @ $72.10 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2023-10-30 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 1,625 @ $0 · Grant/award (A): 3,937 (derivative) @ $0 | EDGAR |
| 2022-10-31 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 338 @ $0 · Grant/award (A): 865 (derivative) @ $0 | EDGAR |
| 2022-05-11 | 4 | BIO-TECHNE Corp (TECH) | Purchase (P): 300 @ $352.55 | EDGAR |
| 2021-11-01 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 194 @ $0 · Grant/award (A): 633 (derivative) @ $0 | EDGAR |
| 2021-08-25 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 4,000 @ $87.39 · Sale (S): 299 @ $481.77 · Sale (S): 601 @ $483.60 · Sale (S): 600 @ $485.03 · Sale (S): 1,600 @ $486.25 · Sale (S): 800 @ $487.10 · +2 more | EDGAR |
| 2020-11-20 | 4 | BIO-TECHNE Corp (TECH) | Option exercise (M): 5,000 @ $66.90 · Sale (S): 5,000 @ $303.33 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2020-11-02 | 4 | BIO-TECHNE Corp (TECH) | Grant/award (A): 391 @ $0 · Grant/award (A): 1,507 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1258704 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs